Macrophage migration inhibitory factor (MIF): a multifaceted cytokine regulated by genetic and physiological strategies

K Sumaiya, D Langford, K Natarajaseenivasan… - Pharmacology & …, 2022 - Elsevier
Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine encoded within a
functionally polymorphic genetic locus. MIF was initially recognized as a cytokine generated …

Pulmonary macrophages: key players in the innate defence of the airways

AJ Byrne, SA Mathie, LG Gregory, CM Lloyd - Thorax, 2015 - thorax.bmj.com
Macrophages are the most numerous immune-cells present in the lung environment under
homoeostatic conditions and are ideally positioned to dictate the innate defence of the …

The immunobiology of MIF: function, genetics and prospects for precision medicine

I Kang, R Bucala - Nature Reviews Rheumatology, 2019 - nature.com
The role of macrophage migration inhibitory factor (MIF) in autoimmunity is underscored by
data showing that common functional polymorphisms in MIF are associated with disease …

MIF but not MIF-2 recruits inflammatory macrophages in an experimental polymicrobial sepsis model

PV Tilstam, W Schulte, T Holowka… - The Journal of …, 2021 - Am Soc Clin Investig
Excessive inflammation drives the progression from sepsis to septic shock. Macrophage
migration inhibitory factor (MIF) is of interest because MIF promoter polymorphisms predict …

Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus

JB Bilsborrow, E Doherty, PV Tilstam… - Expert opinion on …, 2019 - Taylor & Francis
Introduction. Macrophage migration inhibitory factor (MIF) is a pleiotropic inflammatory
cytokine with upstream regulatory roles in innate and adaptive immunity and is implicated in …

Glioblastoma myeloid-derived suppressor cell subsets express differential macrophage migration inhibitory factor receptor profiles that can be targeted to reduce …

TJ Alban, D Bayik, B Otvos, A Rabljenovic… - Frontiers in …, 2020 - frontiersin.org
The application of tumor immunotherapy to glioblastoma (GBM) is limited by an
unprecedented degree of immune suppression due to factors that include high numbers of …

Macrophage migration inhibitory factor drives pathology in a mouse model of spondyloarthritis and is associated with human disease

A Nakamura, F Zeng, S Nakamura, KT Reid… - Science translational …, 2021 - science.org
Spondyloarthritis (SpA), a type 3 immunity-mediated inflammatory arthritis, is a systemic
rheumatic disease that primarily affects the joints, spine, gut, skin, and eyes. Macrophage …

Sensing of Mycobacterium tuberculosis and consequences to both host and bacillus

CE Stamm, AC Collins, MU Shiloh - Immunological reviews, 2015 - Wiley Online Library
Mycobacterium tuberculosis (Mtb), the primary causative agent of human tuberculosis, has
killed more people than any other bacterial pathogen in human history and remains one of …

Tuberculosis vaccine development: progress in clinical evaluation

SB Sable, JE Posey, TJ Scriba - Clinical microbiology reviews, 2019 - Am Soc Microbiol
Tuberculosis (TB) is the leading killer among all infectious diseases worldwide despite
extensive use of the Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccine. A safer …

[HTML][HTML] A multi-targeted approach to suppress tumor-promoting inflammation

AK Samadi, A Bilsland, AG Georgakilas… - Seminars in cancer …, 2015 - Elsevier
Cancers harbor significant genetic heterogeneity and patterns of relapse following many
therapies are due to evolved resistance to treatment. While efforts have been made to …